Jazz Pharmaceuticals PLC (JAZZ) FY2025Q2 Earning Prediction

08/05 04:00:00

After Hours

Jazz Pharmaceuticals PLC (JAZZ) is set to release its earnings performance on 08/05 04:00:00 in After Hours trading. Consensus forecasts predict a revenue of 1.05B and an earnings per share (EPS) of -5.90 for the . With Intellectia's exclusive AI algorithms, users can predict whether the earnings will beat or miss expectations before the report drops. Leverage this powerful tool to strategize and position your trades ahead of the earnings release!

Estimate

Actual

Surprise

RevenueMISS

1.05B

-0.14%

EPSMISS

-5.90

-8.25

-39.83%

AI Summary

Report

Attend Webcast

Earnings Surprise Analysis

The chart displays the extent of earnings surprises and corresponding stock price movements for each earnings event.

Revenue

EPS

JAZZ Transcript

Jazz Pharmaceuticals plc (JAZZ) Presents at Citi Annual Global Healthcare Conference 2025 Transcript

Neutral12-2

Stella-Jones Inc. (SJ:CA) Q3 2025 Earnings Call Transcript

Positive11-5

The earnings call summary and Q&A indicate positive developments such as improved growth expectations for utility poles, strategic partnerships, and potential share gains. Despite challenges in spot market pricing and lowered guidance, the company's operational efficiency and strategic focus on growth opportunities suggest a positive outlook. Additionally, the anticipated FDA approvals and pipeline advancements further support this sentiment. The overall sentiment leans towards a positive stock price movement in the short term.

Jazz Pharmaceuticals plc (JAZZ) Q3 2025 Earnings Call Transcript

Unknown11-5

The earnings call summary presents a mixed outlook. The company shows promise in product development and operational efficiency, but the narrowed revenue guidance and unclear responses in the Q&A section raise concerns. Upcoming FDA approvals and potential blockbuster status for Epidiolex are positives, yet uncertainties in pricing and competition, especially for Xywav, and lack of clear guidance on certain issues temper enthusiasm. Therefore, the overall sentiment is neutral, indicating limited immediate stock price movement.

Jazz Pharmaceuticals Plc (JAZZ) Presents At Wells Fargo 20th Annual Healthcare Conference 2025 Transcript

Neutral9-3

JAZZ Report

Jazz Pharmaceuticals plc 10-Q

10-Q

2024-11-07

Jazz Pharmaceuticals plc 10-Q

10-Q

2024-08-01

Jazz Pharmaceuticals plc 10-Q

10-Q

2024-05-02

Jazz Pharmaceuticals plc 10-K

10-K

2024-02-28

Frequently Asked Questions

What is the Jazz Pharmaceuticals PLC FY2025Q2 Earnings Release Date and Time?

Jazz Pharmaceuticals PLC (JAZZ) is scheduled to release its FY2025Q2 earnings report onAug 5, 2025, After Hours(approximately 4:00 PM ET). This timing allows investors to react during after-hours trading, with a conference call typically following shortly after.

What Are the Consensus Forecasts for Jazz Pharmaceuticals PLC FY2025Q2 Revenue and EPS?

Analysts' consensus predicts 1.05B in revenue and an EPS of -5.90 for Jazz Pharmaceuticals PLC's FY2025Q2.

What Does Intellectia's AI Predict for Jazz Pharmaceuticals PLC FY2025Q2 Earnings?

Intellectia's exclusive AI algorithms forecast a forJazz Pharmaceuticals PLC's FY2025Q2 earnings, with a prediction date of Aug 5, 2025. Jazz Pharmaceuticals PLC

How Can I Use This Earnings Prediction to Trade JAZZ Stock?

Leverage Intellectia's AI forecast to position trades ahead of theAug 5, 2025 release—consider calls for a beat scenario or protective puts for misses. Focus on pre-market volatility, and use the scenario probabilities to build strategies around revenue and guidance updates.

How Accurate Is Intellectia's AI for Earnings Predictions Like Jazz Pharmaceuticals PLC FY2025Q2?

Intellectia's predictions are backed by rigorous backtesting, showing a high hit rate for Beat and Miss calls compared to traditional analysis. While no forecast is 100% certain, we provide probability-based scenarios (e.g., 50% chance of a *Beat*) and detailed rationales to help you make informed decisions. Combine our insights with your strategy for the best results—it's like having a co-pilot for earnings season! Empowering users to strategize trades before reports drop.

How does AI Earnings Prediction generate its forecasts?

AI Earnings Prediction uses advanced Large Language Models (LLMs) to analyze a wealth of data, including past earnings transcripts, real-time market sentiment, analyst insights, and company news from the last three months. It focuses on key indicators like revenue, EPS, and margins to predict whether a company will *Beat*, *Miss*, or remain Neutral relative to market expectations. Think of it as a super-smart analyst crunching numbers and news 24/7 to give you a trading edge!

When are the predictions available, and how often are they updated?

Predictions are generated two days before a company’s earnings release (e.g., 5:00 PM ET on Feb 13 for a Feb 15 report) to capture the latest market and company data. They’re updated in real-time if significant news breaks, ensuring you get fresh insights.

Can I use AI Earnings Prediction for all types of stocks?

Currently, AI Earnings Prediction focuses on companies with market caps above $40 billion, covering major players like SPG, AAPL, MSFT, and NVDA for the 2024-2025 earnings seasons. We prioritize high-impact stocks with robust data to ensure reliable forecasts. Stay tuned as we expand coverage to more companies based on user demand!